According to all spectroscopic data, msh4 is monodaentate and coordinate via thiophene ring sulfur.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The new complexes, [M(CO)5(msh4)] (Cr(1), Mo(2), W(3)), have been synthesized by the photochemical reaction of metal carbonyls with 2-acetyl-5-chlorothiophenemethanesulfonylhydrazone(msh4) .The structure of these complexes has been investigated by using elemental analyses; FT-IR; EI-MS and 1H NMR spectrometric methods.
📊
Key Findings & Data:The new complexes, [M(CO)5(msh4)] (Cr(1), Mo(2), W(3)), have been synthesized by the photochemical reaction of metal carbonyls with 2-acetyl-5-chlorothiophenemethanesulfonylhydrazone(msh4) .The structure of these complexes has been investigated by using elemental analyses; FT-IR; EI-MS and 1H NMR spectrometric methods.
💡
Conclusion & Impact:According to all spectroscopic data, msh4 is monodaentate and coordinate via thiophene ring sulfur.
The new complexes, [M(CO)5(msh4)] (Cr(1), Mo(2), W(3)), have been synthesized by the photochemical reaction of metal carbonyls with 2-acetyl-5-chlorothiophenemethanesulfonylhydrazone(msh4) .The structure of these complexes has been investigated by using elemental analyses; FT-IR; EI-MS and 1H NMR spectrometric methods. According to all spectroscopic data, msh4 is monodaentate and coordinate via thiophene ring sulfur.
Özet
The new complexes, [M(CO)5(msh4)] (Cr(1), Mo(2), W(3)), have been synthesized by the photochemical reaction of metal carbonyls with 2-acetyl-5-chlorothiophenemethanesulfonylhydrazone(msh4) .The structure of these complexes has been investigated by using elemental analyses; FT-IR; EI-MS and 1H NMR spectrometric methods. According to all spectroscopic data, msh4 is monodaentate and coordinate via thiophene ring sulfur.
G.Domagk, Deut. Med. Wochenschr. 61(1935) 250. G.I.Mandell, W.A.Petri, J.G.Hardman, L.E.Limbird, P.B.Molinoff, R.W.Ruddon, A.G.Gilman, Goodman’s the Pharmacological Basis of Therapeutics, 9th ed.,McGraw-Hill, New York, 1996.
N.R.Lomax, LV.L.Narayanan, Chemical Structures of Interest to the Division of Cancer Treatment, Vol. VI, Developmental Therapeutics Program, National Cancer Institue, Bethesda,MD, p.32(1988).